Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Carol Aghajanian

1-50 of 214 results

View this query on the Wikidata Query Service
OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

scientific article published on April 23, 2012
Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.

scientific article
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial

scientific article published on 12 September 2017
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

article
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm

scientific article published on 23 April 2009
The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC–IV epithelial ovarian cancer

article
The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center

scientific article
Phase II Trial of Bevacizumab in Recurrent or Persistent Endometrial Cancer: A Gynecologic Oncology Group Study

scientific article published on May 2, 2011
Clinical activity of pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in advanced ovarian cancer: potential predictive relationship with tumor HER2 activation status

article
Identification of six new susceptibility loci for invasive epithelial ovarian cancer

scientific article published on 12 January 2015
Genomic complexity and AKT dependence in serous ovarian cancer

scientific article published on January 2012
A phase I trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies

scientific article
A phase II evaluation of the potent, highly selective PARP inhibitor veliparib in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who carry a germline BRCA1 or BRCA2 mutation - An

scientific article published on March 24, 2015
Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma

scientific article published on 01 May 2006
Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient.

scientific article published on August 2017
Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study

scientific article published on 9 January 2009
BRAF Mutation is associated with early stage disease and improved outcome in patients with low‐grade serous ovarian cancer

scientific article published on August 28, 2012
Pilot study of a heptavalent vaccine-keyhole limpet hemocyanin conjugate plus QS21 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer

scientific article
Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancer.

scientific article published on 10 August 2015
A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer

scientific article published on 11 July 2014
Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy

scientific article published on 23 December 2015
Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study

scientific article
Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission.

scientific article published in May 2008
Early detection and prognosis of ovarian cancer using serum YKL-40.

scientific article published in August 2004
The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer

scientific article published on 11 December 2007
Phase I study of the novel epothilone analog ixabepilone (BMS-247550) in patients with advanced solid tumors and lymphomas

scientific article
Analysis of patients with epithelial ovarian cancer or fallopian tube carcinoma retreated with cisplatin after the development of a carboplatin allergy

scientific article published in March 2002
Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash

scientific article published on 21 January 2009
Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology

scientific article published on 10 December 2013
Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology

scientific article published on 5 December 2011
Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma

scientific article
Squamous cell carcinoma arising in mature cystic teratoma of the ovary: a case series and review of the literature

scientific article published on 22 January 2007
Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial

scientific article published on 25 March 2019
Improved survival for BRCA2-associated serous ovarian cancer compared with both BRCA-negative and BRCA1-associated serous ovarian cancer

scientific article published on 2 December 2011
Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center

scientific article
Phase II study of CT-2103 in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma

scientific article published in November 2004
Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations

scientific article published on 30 June 2016
Phase 1 study of aflibercept administered subcutaneously to patients with advanced solid tumors

scientific article
A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study

scientific article published on 26 August 2009
A phase II study of cetuximab/paclitaxel/carboplatin for the initial treatment of advanced-stage ovarian, primary peritoneal, or fallopian tube cancer

article
Treatment of advanced uterine leiomyosarcoma with aromatase inhibitors

scientific article published on 24 November 2009
Role of pegylated liposomal doxorubicin in ovarian cancer

scientific article
Retrospective analysis of carboplatin and paclitaxel as initial second-line therapy for recurrent epithelial ovarian carcinoma: application toward a dynamic disease state model of ovarian cancer

scientific article published in March 2002
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer

scientific article published on 28 September 2019
Cancer-related infertility in survivorship

scientific article published on January 2010
Extreme Outlier Analysis Identifies Occult Mitogen-Activated Protein Kinase Pathway Mutations in Patients With Low-Grade Serous Ovarian Cancer

scientific article
CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy

scientific article published on 25 September 2006
Paclitaxel and carboplatin in the adjuvant treatment of patients with high-risk stage III and IV endometrial cancer: a retrospective study

scientific article
Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer

scientific article published on September 2006
Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer

scientific article

Paulina is supported by:

About Paulina

Help